Navigation Links
BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees
Date:12/2/2008

SANTA BARBARA, Calif., Dec. 2 /PRNewswire/ -- BioIQ, the leader in consumer-friendly health testing products and services, and Alere(R), who provides services that include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions to health plans, employers, and government agencies, will work together to supply BioIQ's home-test kits and online reporting tools as part of Alere's Personal Health Solutions.

"In today's increasingly virtual world, more employees are working remotely, either from home or satellite locations," said Dr. Ron Geraty, CEO of Alere. "By identifying risk factors early, we can in many cases minimize the impact of conditions such as diabetes, heart disease, hypertension and obesity. With this expanded Screening Services offering, Alere will be able to reach both employees and dependents more effectively."

As part of this workplace-wellness initiative, participants of Alere's Screening Services Programs will order BioIQ test kits via a secure website, which are then mailed to their homes. Each kit includes instructions for drawing a small blood sample through a simple finger-prick method and mailing it to a certified laboratory for analysis. Measurements include high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglycerides, hemoglobin/A1c, and fasting glucose. A single-sign-on login process will enable Alere participants to seamlessly access BioIQ's enrollment and lab results pages via secure personal accounts. In addition, the results from the BioIQ tests will be automatically loaded into each participant's Health & Productivity Assessment and Personal Health Record, which are part of Alere's Wellness Solutions.

"BioIQ adds to Alere's current on-site and in-home screening offering, enabling them to screen more people and more effectively identify health risks," said Justin Bellante, CEO at BioIQ. "Biometric testing leads to more effective interventions, treatment, and follow-up."

About BioIQ

BioIQ (www.bioiq.com) is a healthcare information technology company that develops and markets medical diagnostic solutions through corporate, institutional and direct-to-consumer channels. The company's affordable and innovative home test kits are commonly used to monitor or screen for diabetes, cancer, heart disease, kidney disease, thyroid disorder, osteoporosis, and other chronic health conditions.

About Alere

Alere is a member of the Inverness Medical Innovations (www.invernessmedical.com) family of companies and represents the union of Alere Medical, ParadigmHealth and Matria(R) Healthcare. Alere is the Latin verb meaning "to care for" or "to support". Services include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions and high-risk pregnancy and NICU management. In addition, in-home diagnostics monitoring devices address the need for the daily monitoring of medium- and high-risk patients. Inverness Medical Innovations is a global leader in rapid point-of-care diagnostics, cardiology, oncology, women's health and health management services. More information can be found about Alere at www.alere.com.

(C) 2008 Inverness Medical. All rights reserved. Alere and Matria are trademarks of the Inverness Medical group of companies.


'/>"/>
SOURCE BioIQ
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Software Vendor QAD Rolls Out BioIQ Health Testing Program to National Workforce
2. Inverness Medical Innovations Acquires Alere Medical
3. Avalere Study Shows Medicare Part D Helping People with Type 2 Diabetes; Warns People with Diabetes of Probability of Reaching the Donut Hole
4. Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans
5. Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File
6. Avalere Examines Emerging Strategies for Managing Imaging Utilization
7. Study provides hope that some transplant patients could live free of antirejection drugs
8. Study provides hope that some transplant patients could live free of anti-rejection drugs
9. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. USAID Provides Additional Wildfire Assistance to Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of Australia ... attended the January ECRM trade show in Hilton Head, SC. , International Protein ... to create a line of products that would elevate her fitness regime. At this ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing ... “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, ... , When asked of her new book, Marjorie says, “‘The Angel’ was written as ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... the Aerolib Learning Management System: an On-demand E-learning system for Clinical and ... Hospital Administration that is based on Aerolib`s successful education methodology of Disease ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017 Wells Specialty Pharmacy announces ... Howell Branch Rd in Winter Park, Florida ... Park . Operations have been consolidated into the 3796 ... also pleased to announce that Chad Tomlinson , former ... the Company effective immediately. Mr. Tomlinson is a Graduate of ...
(Date:1/20/2017)... 20, 2017 Avillion LLP, a co-developer and ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg ... USA . ... Dr Weinberg has spent more than 17 years as a pharmaceutical ... to micro-cap biotech. Over the course of his career, he has ...
(Date:1/19/2017)... Jan. 19, 2017 The global immunomodulators ... by 2025, according to a new study by ... to be predominantly driven by high R&D investments ... large-scale production of new and therapeutically advanced drugs. ... drugs at an unprecedented rate into the immunomodulators ...
Breaking Medicine Technology: